Scandinavian ChemoTech AB (publ)

medical devices

About

ChemoTech is a R&D based company in the field of oncology. The Company is presently marketing and selling it's IQwave™ TSE (Tumour Specific Electroporation™) system which is an innovation within the field of electroporation. ChemoTech's products are presently available in Europe, India and South East Asia. The treatment is developed to treat patients with large and 'hard to treat' superficial tumours. ChemoTech's shares (CMOTEC B) are listed on NASDAQ First North in Stockholm. The Company is headquartered in Lund, Sweden. We have also a device for our Animal Care division called vetIQure™, this device is being marketed and handled by our subsidiary Vetiqure AB. Our vision By being devoted to clinical development and scientific excellence, ChemoTech aspires to be a force for better cancer care. Our aim is to always deliver cost and treatment efficient technologies that improve the quality of live to those suffering from cancer and their love ones.

Technologies

Cloudflare DNS CloudFlare Hosting reCAPTCHA Mobile Friendly WordPress.org Shutterstock

Keywords

cancer treatments research clinical development chemotherapy immunotherapy treatment protocols b2b government immune activation medical devices robotic-assisted procedures tse technology iqwave healthcare immunomodulation tumour specific electroporation low-dose chemotherapy multi-dimensional electric field minimally invasive low energy levels reversible electroporation cancer therapy biotechnology clinical trials palliative care in oncology advanced hardware tumor treatment electroporation cost-effective treatment ce-marked product

Location

1 Scheelevaegen, Lund, Skane County, Sweden, 223 49

Related Companies

Companies in the same industry